DescriptionThe online Oncology Nursing Society (ONS) Chemotherapy and Immunotherapy Certificate Program provides nurses with a comprehensive overview of chemotherapy and immunotherapy. The in-person Bridge to Practice sessions review NIH specific policies and procedures related to chemotherapy/immunotherapy administration at NIH. The ONS Chemotherapy/Immunotherapy Certificate is obtained after successful completion of the course including a course exam. An 80% or higher must be achieved on the exam before an RN can receive the certificate. The provider card is valid for two years. The Clinical Center Nursing Department (CCND) program of care competency for chemotherapy and biotherapy requires successful completion of a chemotherapy course including an examination and clinical practicum (to be completed on the patient care unit) prior to administering chemotherapy or biotherapy.
Contact Hours15.25 contact hours Special CommentsTo be successful in the course, RNs need to attend three 8 hour sessions.
Target AudienceClinical Center Nursing Department RNs administering chemotherapeutic/biotherapy agents to adult patients with oncology and non-oncology diagnoses. Course Objectives1. Discuss commonly used agents, their mechanisms of action, and any unique administration issues.
Pre-requisites1. Have the goal of obtaining the Clinical Center Nursing Department "Chemotherapy and Biotherapy" competency. 2. Have practiced in the Clinical Center for at least 6 months. 3. Have taken the Clinical Center Nursing Department's (CCND) Oncology Education Series: ONS online "Cancer Basics", "Oncologic Emergencies." OCC CRNS additionally need to attend "OES:Concepts, Trends, and Care." 4. Hold a current CCND "Safe Handling of Hazardous Drugs" competency. Special population: CCND CRNs who currently hold the "Chemotherapy/Biotherapy competency and have completed the Chemotherapy Biotherapy for Non-oncology Setting" course are eligible to take this course without taking the additional pre-requisites. Contact Meg Mikula mmikula@cc.nih.gov with any questions. |
|